Harnessing natural killer T cells to stop cancer

It’s always great to see articles and documents I’ve worked on make their way into the world.

This one was for RIKEN in Japan.

Researchers at the RIKEN Center for Integrative Medical Sciences (IMS) are investigating a number of immunology and cancer therapies, and our team at the RIKEN IMS Laboratory for Developmental Genetics is spearheading efforts to develop new cancer immunotherapy strategies by harnessing the power of natural killer T (NKT) cells.

Leave a Reply

Your email address will not be published.